Features | Partner Sites | Information | LinkXpress
Sign In
AMPRONIX
SCHILLER AG
TERARECON, INC.

MRI Study to Offer New Strategies for Chronic Kidney Disease Treatments

By Medimaging International staff writers
Posted on 26 Feb 2014
Detailed structural and functional maps of the human kidney generated using cutting-edge scanning technology are being developed in an effort to optimize treatment strategies for those suffering from chronic kidney disease.

The research, conducted by scientists from the University of Nottingham (UK), is being funded with GBP 107,623 from the Dr. Hadwen Trust, a non-animal biomedical research charity. The goal of the project is to try to further determine of how the kidneys function, ultimately leading to enhanced monitoring, and treatment for chronic kidney disease. It will be the first of its kind to use magnetic resonance imaging (MRI) to study the role oxygen plays in keeping the human kidney healthy.

The study is being led by Dr. Sue Francis at the University’s Sir Peter Mansfield Magnetic Resonance Center in collaboration with Prof. Chris McIntyre at the University’s School of Medicine. Dr. Francis said, “Current tests for chronic kidney disease can be very invasive and patients may need to return to the hospital on a number of occasions. The aim of this project is to produce a set of noninvasive measurements that we can produce in a single, one-hour scanning session that can assess the blood flow and oxygenation of the kidney and which could eventually be rolled out in a clinical setting to benefit patients.”

Disease is now diagnosed by a blood test that measures the glomerular filtration rate (GFR). In more serious kidney disorders, a renal biopsy may need to be performed. Dr. Francis added, “Current methods can only offer a fairly crude picture of what is happening in the kidneys and how that is changing over time. For example, if one kidney is doing most of the work it can be difficult to tell and taking just a small sample of tissue from one area of the kidney may not be representative of the organ as a whole.”

The study will instead use magnetic resonance imaging (MRI), powered by a 3-Tesla magnet, to scan the kidney and construct a comprehensive image of perfusion in the kidney. It will also measure the metabolic rate of oxygen, which has not been done before using MRI technology. The research will employ new MRI technology, and use these techniques in healthy volunteers to study the kidney’s response to oxygen and CO2 changes to evaluate how the kidney acts under stress, which mimics diseased kidneys. Next, the researchers will scan 20 patients with diabetic nephropathy in an effort to validate the effectiveness of their approach. The scanning technique could be used to monitor the progression of a patient’s disease and to monitor the effect and effectiveness of drugs being used to treat the disorder.

Related Links:

University of Nottingham 



RTI ELECTRONICS AB
RADCAL
SuperSonic Imagine

Channels

Radiography

view channel

Leading Cancer Center Among First in Europe to Treat Patients Using Robotic Patient-Positioning Radiotherapy Couch

A Viennese hospital has become one of the first oncology departments in Europe to introduce clinical treatments using a robotic radiotherapy patient-positioning couch. Kaiser-Franz-Josef Hospital (KFJ; Vienna, Austria) has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy... Read more

Ultrasound

view channel
Image: Analogic Sonic Window handheld ultrasound for peripheral IV placement (Photo courtesy of Analogic).

First-of-a-Kind Ultrasound System Designed for Image-Guided Peripheral Intravenous Access and Fits in Pocket

A new, ultra-compact ultrasound device provides direct visualization of structures beneath the skin in real time to effectively guide clinicians placing peripheral intravenous (IV) lines.... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.